CDC25B and triple-negative breast carcinoma: Since glucose concentration was found to influence metformin sensitivity in previous studies (41), we also tested CDC25B knockdown under low glucose condition and observed a similar resistance effect to metformin in triple negative breast cancer cells (Supplementary Figure S7).